Page 253 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 253

PP-70


               Plant-derived  exosome-like  nanovesicles:  Arctium  lappa  L.-derived

               nanovesicles induce pyroptosis of lung carcinoma cells in vivo and in vitro


                                                                 1,2
                                                                                 1,2
                                            1,2
               Jae Heon Sim,  #,1,2  Mina Boo,  Hyunyoung Choi,  Suhyeon An,  HyunSoo Yang,
                                                                                                   1,2
                                  2
               Dong-Hyun Youn,  Hye-Lin Kim,  Jinbong Park*       ,2
                                                 2

               1  Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul,
                 Republic of Korea
               2  Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul,
                 Republic of Korea
               * E-mail: thejinbong@khu.ac.kr

               Abstract
                  Plant-derived  exosome-like  nanovesicles  have  recently  emerged  as  promising  natural
               therapeutics due to their biocompatibility, stability, and capacity to transport diverse bioactive
               molecules. In this study, we investigated the anti-cancer efficacy of Arctium lappa L.-derived
               exosome-like  nanovesicles  (ALDENs),  with  a  particular  focus  on  their  ability  to  induce
               pyroptosis in lung carcinoma. In vitro, treatment of murine Lewis lung carcinoma (LLC1) cells
               with ALDENs  triggered  robust  activation  of  the  NOD-like  receptor  family  pyrin  domain
               containing 3inflammasome (NLRP3), leading to caspase-1 activation, gasdermin D (GSDMD)
               cleavage,  and  consequent  pyroptotic  cell  death.  These  processes  were  accompanied  by  a
               significant increase in Interleukin-1 beta (IL-1β) secretion and elevated lactate dehydrogenase
               (LDH)  release,  consistent  with  pyroptotic  activity.  Immunofluorescence  analysis  further
               confirmed  enhanced  expression  and  co-localization  of  ASC  and  NLRP3  in  LLC1  cells
               following ALDENs treatment. In vivo, subcutaneous implantation of LLC1 cells in C57BL/6
               mice followed by oral administration of ALDENs significantly suppressed tumor growth and
               reduced  tumor  burden  compared  with  control  groups.  Importantly,  immunofluorescence
               staining  of  tumor  tissues  revealed  upregulated  Apoptosis-associated  speck-like  protein
               containing  a  CARD  (ASC)  and  NLRP3  expression  within  the  tumor  microenvironment,
               indicating  inflammasome  activation  in  vivo.  No  evidence  of  hepatic  or  renal  toxicity  was
               observed, supporting the favorable safety profile of ALDENs. In result, these findings identify
               ALDENs as a safe, plant-derived nanotherapeutic capable of exerting anti-tumor activity by
               inducing inflammasome-dependent pyroptosis. The novelty of this work lies in demonstrating
               that orally delivered plant-derived nanovesicles can activate pyroptotic cell death both in vitro
               and in vivo, thereby positioning ALDENs as a promising natural therapeutic strategy for the
               treatment of solid tumors such as lung carcinoma.

               Keywords: Arctium lappa; Plant-derived exosome-like nanovesicles; Pyroptosis; Lung cancer
   248   249   250   251   252   253   254   255   256   257   258